Skip to main content

Table 1 Clinical characteristics and outcome of 18 patients with idiopathic VF

From: Recurrent cardiac events in patients with idiopathic ventricular fibrillation, excluding patients with the Brugada syndrome

Baseline Characteristics

ICD Therapy

Patient

Age (years) sex

CE

Drug test to exclude Brugada

PES

AS

NSVT

IS

Ind S

Time to 1st AS (months)

Follow-up (months)

AAD during follow-up

1

47,M

Sy-VF

F

SMVT

6

7

-

-

4

17

sotalol

2

51,F

CA

F

NI

7

21

-

-

1

19

sotalol

3

66,M

CA

AJ

VF

-

-

-

-

-

5

-

4

70,F

CA

P

NI

-

-

6(af)

-

-

19

amiodarone

5

46,M

CA

F

NI

-

1

1(af)

-

-

23

sotalol

6

20,M

Sy-VF

A

VF

-

-

3(st-lp)

-

-

92

b-blocker

7

46,F

CA

P

VF

-

120

-

-

-

27

sotalol

8

40,M

CA

A

NSVT

1

-

-

-

13

75

-

9

33,M

Sy-VF

F

NSVT

-

1

-

-

-

19

-

10

26,M

CA

F

NI

1

-

3(st-lp)

-

7

9

sotalol

11

33,F

CA

F

NI

-

-

-

-

-

18

-

12

50,F

CA

F

SMVT

6

-

1(st)

-

13

86

flecainide

13

25,M

CA

AJ + P

NSVT

-

1

-

-

-

62

-

14

36,M

CA

AJ

NI

2

-

2(af)

4

27

55

sotalol

15

58,M

Sy-VF

AJ

NI

-

-

3(af)

2

-

57

sotalol

16

44,M

CA

F + P

NI

-

-

-

-

-

48

-

17

28,M

Sy-VF

F

VF

4

-

2(st)

-

18

55

sotalol

18

35,M

Sy-VF

A

SMVT

-

-

-

-

-

59

-

  1. CE: clinical events; CA: cardiac arrest; Sy-VF: syncope with documented self-terminating polymorphic VT or VF
  2. PES: programmed electrical stimulation; M: male; F: female
  3. SM: sustained monomorphic; VT: ventricular tachycardia; VF: ventricular fibrillation
  4. NS: non sustained; NI: non inducibility; af: atrial fibrillation; st: sinus tachycardia; lp: lead problem
  5. AS: appropriate shock; IS: inappropriate shock; Ind S: indeterminate cause for shocks;
  6. AAD: antiarrhythmic drug; F: flécaïnide; AJ: ajmaline; P: procainamide